Global Antacids Market Size, Share, Industry Growth Analysis 2020, & Forecast 2021-2026 (Includes Business Impact of COVID-19)

  • TBI217704
  • August 01, 2019
  • Global
  • 132 pages
  • HCCResearch
                                          

Abstract, Snapshot, Market Analysis & Market Definition: Global Antacids Market

The global Antacids market size is projected to reach US$ 8.23 billion by 2026, from US$ 6.54 billion in 2020, at a CAGR of 3.9% during 2021-2026. Changing dietary habits is one of the major factors expected to fuel the growth during the forecast period. Increasing prevalence of Gastro Esophageal Reflux Diseases (GERD) is expected to affect the overall market over the forecast period. According to the Gut journal, published by the International Foundation for Gastrointestinal Disorders; in 2017, the prevalence of GERD was around 18% to 28% in North America, 9% to 26% in Europe, 3% to 8% in East Asia, 9% to 33% in Middle East, 12% in Australia, and 23% in South America. Furthermore, increasing awareness about GERD is anticipated to boost the antacids market. According to an article published in the International Foundation for Gastrointestinal Disorders, the 19th Annual GERD Awareness Week was in November, 2018 which provided information and support regarding this condition. Also, International Foundation for Functional Gastrointestinal Disorders (IFFGD) encourages patients suffering from GERD-related symptoms, to consult their physicians. In addition, increasing prevalence of heartburn is estimated to affect the market over the forecast period. According to an article published in the Medical Xpress, a web-based medical and health news service; in 2017, researchers from the University of Michigan identified that acid reflux and heartburn affected more than 20% of the U.S. population.

Market Segmentation, Outlook & Viewpoint: Global Antacids Market

Dosage Form Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

  • Tablet
  • Liquid
  • Others

Distribution Channel Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Key Players, Recent Developments & Regional Insights: Global Antacids Market

Based on distribution channel, the market is trifurcated into hospital pharmacy, retail pharmacy, and online pharmacy. In 2017, retail pharmacy held the largest market share due to easy accessibility and availability of these pharmacies. For instance, MedPlus has around 1,400 outlets out of which 1,350 are self-owned and rest are taken as a franchisee. Online pharmacy is estimated to be the fastest growing segment over the forecast period owing to increasing awareness among consumers. According to a survey conducted by Alliance For Safe Online Pharmacies (ASOP Global) in 2017, 33% of survey participants from Canada had purchased prescription medicines from an online pharmacy. People are opting for online pharmacies owing to lucrative offers, such as price discounts, ease in availability of drugs and home delivery services. In addition, growing adoption of information technology in healthcare sector is enabling clinicians to send prescriptions electronically, which is expected to boost the growth.

Regional Insights

Asia Pacific is expected to be the largest and fastest growing regional segment during the forecast period owing to high unmet clinical needs, availability of effective treatment methods, rising disposable income, and consumer awareness about the availability of these products. In addition, the presence of key players, such as GlaxoSmithKline plc.; Pfizer Inc.; Abbott is anticipated to grow the market over the forecast period. Improving healthcare infrastructure, and growing investments by market players is expected to increase its growth. North America is estimated to be the second largest growing segment. This was attributed to increasing digestive disorder prevalence coupled with consumer awareness of antacid products. In 2017, according to the CDC, the number of visits in emergency departments with digestive system diseases as the primary diagnosis was around 32.3 million. Furthermore, the presence of developed economies within the region is adding fuel to its growth in this region.

Antacids Market Share Insights

The overall market is likely to face intense competition over the forecast period owing to the presence of multinational players and small-scaled companies. Geographical expansion, and joint ventures are some of the key strategies undertaken by key players in the market. For instance, in 2016, Takeda Pharmaceutical Company Limited,launched first and approved proton pump inhibitor, Dexilant (Dexlansoprazole), which uses dual delayed release technology for patients with GERD. Some of the key players are GlaxoSmithKline plc; Bayer AG; Boehringer Ingelheim International GmbH;Dr. Reddys Laboratories Ltd.; Sanofi; Reckitt Benckiser Group plc; Sun Pharmaceuticals Ltd.; Takeda Pharmaceutical Company Limited; Pfizer Inc.; and Procter & Gamble.

Key Insights Covered: Global Antacids Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Antacids industry. 2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Antacids industry. 3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Antacids industry. 4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Antacids industry. 5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Antacids industry.

Research Methodology: Global Antacids Market

  • Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  • Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  • Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other

Table of Contents
Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Scope And Assumptions
1.3 List Of TablesChapter 2 Executive Summary
2.1 Market SummaryChapter 3 Market Variables, Trends & Scope
3.1 Market SegmentationChapter 4 Market DefinitionsChapter 5 Industry Outlook
5.1 Market Variable Analysis
    5.1.1 Increasing Prevelance Of Gastro Esophageal Reflux Diseases (GERD)
    5.1.2 Growing Geriatric Population
    5.1.3 Increasing Prevalence Of Heartburn
5.2 Market Restraint Analysis
    5.2.1 Growing Number Of Alternatives In The Market For AntacidsChapter 6 Business 
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form